Learning from Bacteriophages - Advantages and limitations of Phage and Phage-Encoded protein Applications

Current Protein and Peptide Science

Volumn 13, Issue 8, 2012, Pages 699-722

  Drulis Kawa, Zuzanna ^a   Majkowska Skrobek, Grazyna ^a   Maciejewska, Barbara ^a   Delattre, Anne Sophie ^b   Lavigne, Rob ^b  

^a UNIVERSITY OF WROC AW   (Poland)

^b LABORATORY OF GENE TECHNOLOGY   (Belgium)

Author keywords

Antibiotics; Bacterial multidrug resistance; Bacteriophage therapy; Phage encoded proteins application

Indexed keywords

AMINOGLYCOSIDE; ARTILYSINS; BACTERIOPHAGE DNA; BACTERIOPHAGE RECEPTOR; CARBAPENEMASE; CEPHALOSPORIN; CHLORAMPHENICOL; DAPTOMYCIN; EXOPOLYSACCHARIDE; GLYCYLCYCLINE DERIVATIVE; INT 401; KETOLIDE; LINCOMYCIN; LIPOPOLYSACCHARIDE; LISTEX P100; LISTSHIELD; MACROLIDE; NITROIMIDAZOLE; OLIGOSACCHARIDE; OUTER MEMBRANE PROTEIN A; OXAZOLIDINONE DERIVATIVE; PENICILLIN DERIVATIVE; PEPTIDOGLYCAN; PHAGE EARLY PROTEIN; PHAGE ENCODED PROTEIN; PHAGE LATE PROTEIN; PLSV 1; PROTEIN; QUINOLONE; RIFAMYCIN; SALMONELEX; SALMOSHIELD; SASP JECT; SHIGAACTIVE; SMARTPHAGE; SPL; STREPTOGRAMIN DERIVATIVE; TEICHOIC ACID; TETRACYCLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANCOMYCIN; VIRIDAX;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; BACTERIAL GENETICS; BACTERIOLYSIS; BACTERIOPHAGE; BACTERIUM ADHERENCE; BACTERIUM TRANSCRIPTION; CELL DIVISION; DNA REPLICATION; DOWN REGULATION; DRUG MANUFACTURE; HUMAN; INFECTION; NONHUMAN; PHAGE PROGENY; PHARMACODYNAMICS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVIEW; UPREGULATION; VIRUS ASSEMBLY;

ANTI-BACTERIAL AGENTS; BACTERIOPHAGES; DRUG RESISTANCE, BACTERIAL; VIRAL PROTEINS;

EID: 84874833162     PISSN: 13892037     EISSN: 18755550     Source Type: Journal    
DOI: 10.2174/138920312804871193     Document Type: Review

References (266)

1. Twort, F.W. An investigation on the nature of the ultramicroscopic viruses. Lancet, 1915, 186, 1241-1243.
2. d'Hérelle, F. Sur un microbe invisible antagoniste des bacilles dysentériques. C. R. Acad. Sci. Ser. D, 1917, 165, 373-375.
3. Sakandelidze, V.M.; Meipariani, A.N. Use of combined phages in supparative-inflammatory diseases. Zh. Mikrobiol. Epidemiol. Immunobiol., 1974, 6, 135-136.
4. Zhukov-Verezhnikov, N.N.; Peremitina, L.D.; Berillo, E.A.; Komissarov, V.P.; Bardymov, V.M.; Khvoles, A.G.; Ugryumov, L.B. A study of the therapeutic effect of bacteriophages agents in a complex treatment of suppurative surgical diseases. Sov. Med., 1978, 12, 64-66.
5. Richardson, J.F.; Rosdahl, V.T.; van Leeuwen, W.J.; Vickery, A.M.; Vindel, A.; Witte, W. Phages for methycillin-resistant Staphylococcus aureus: an international trial. Epidemiol. Infect., 1999, 122, 227-233.
6. Weber-Dabrowska, B.; Mulczyk, M.; Górski, A. Bacteriophage Bacteriophage therapy of bacterial infections: an update of our Institute's experience. Arch. Immunol. Ther. Exp., 2000, 48, 547-551.
7. Weber-Dabrowska, B.; Mulczyk, M.; Górski, A. Bacteriophage therapy for infections in cancer patients. Clinical. Applied. Immunol. Rev., 2001, 1, 131-134.
8. Weber-Dabrowska, B.; Mulczyk, M.; Górski, A. Bacteriophages as an efficient therapy for antibiotic-resistant septicemia in man. Transp. Proc., 2003, 35, 1385-1386.
9. Sulakvelidze, A.; Alavidze Z.; Morris, J. G. Bacteriophage therapy. Antimicrob. Agents Chemother., 2001, 45, 649-659.
10. Drulis-Kawa, Z.; Weber-Dabrowska, B.; Lusiak-Szelachowska, M.; Doroszkiewicz, W. Potential possibilities of using phage typing in elimination of multidrug resistant staphylococci. Pol. J. Microbiol., 2005, 54, 63-67.
11. Drulis-Kawa, Z.; Mackiewicz, P.; Kesik-Szeloch, A.; Maciaszczyk-Dziubinska, E.; Weber-Dabrowska, B.; Dorotkiewicz-Jach, A.; Augustyniak, D.; Majkowska-Skrobek, G.; Bocer, T.; Empel, J.; Kropinski, A.M. Isolation and characterization of KP34-a novel φKMV-like bacteriophage for Klebsiella pneumoniae. Applied Microbiol. Biotechnol., 2011, 90, 1333-1345.
12. Slopek, S.; Durlakova, I.; Weber-Dabrowska, B.; Kucharewicz-Krukowska, A.; Dabrowski, M.; Bisikiewicz, R. Results of bacteriophage treatment of suppurative bacterial infections I. General evaluation of the results. Arch. Immunol. Ther. Exp., 1981, 31, 267-291.
13. Slopek, S.; Durlakova, I.; Weber-Dabrowska, B.; Kucharewicz-Krukowska, A.; Dabrowski, M.; Bisikiewicz, R.; Results of bacteriophage treatment of suppurative bacterial infections II. Detailed evaluation of the results. Arch. Immunol. Ther. Exp., 1981, 31, 293-327.
14. Slopek, S.; Durlakova, I.; Weber-Dabrowska, B.; Dabrowski, M.; Kucharewicz-Krukowska, A. Results of bacteriophage treatment of suppurative bacterial infections III. Detailed evaluation of the results obtained in further 150 Cases. Arch. Immunol. Ther. Exp., 1984, 32, 317-335.
15. Górski, A.; Weber-Dabrowska, B. The potential role of endogenous bacteriopfages in controllin invading pathogens. Cell. Mol. Life Sci., 2005, 62, 1-9.
16. Barrow, P.A.; Soothill, J.S. Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential. Trends Microbiol., 1997, 5, 268-271.
17. Brüssow, H. Phage therapy: the Escherichia coli experience. Microbiol., 2005, 151, 2133-2140.
18. O'Flaherty, S.; Ross R.P.; Coffey A. Bacteriophage and their lysins for elimination of infectious bacteria. FEMS Microbiol. Rev., 2009, 33, 801-819.
19. Courchesne, N.M.; Parisien, A.; Lan, C.Q. Production and application of bacteriophage and bacteriophage-encoded lysins. Recent Pat. Biotechnol., 2009, 3, 37-45.
20. Fischetti, V.A. Bacteriophage lysins as effective antibacterials, Curr. Opin. Microbiol., 2008, 11, 393-400.
21. Labrie, J.; Samson, J.E.; Moineau, S. Bacteriophage resistance mechanisms. Nat. Rev., 2010, 8, 317-327.
22. Overbye, K.M.; Barrett, J.F. Antibiotics: where did we go wrong. Drug Disc. Today, 2005, 10, 45-52.
23. Walsh, C. Where will the new antibiotics come from? Nat. Rev. Microbiol., 2003, 1, 65-70.
24. Giedraitiene, A.; Vitkauskiene, A.; Naginiene, R.; Pavilonis, A. Antibiotic resistance mechanisms of clinically important bacteria. Medicina, 2011, 47, 137-146.
25. Gniadkowski, M. Evolution and epidemiology of extendedspectrum beta-lactamases (ESBLs) and ESBL-producing microorganisms. Clin. Microbiol. Infect., 2001, 7, 597-608.
26. Nijssen, S.; Florijn, A.; Bonten, M.J.M.; Schmitz, F.J.; Verhoef, J.; Fluit, A.C. Beta-lactam susceptibilities and prevalence of ESBLproducing isolates among more than 5000 European Enterobacteriaceae isolates. Int. J. Antimicrob. Agents, 2004, 24, 585-591.
27. Coque, T.M.; Baquero, F.; Canton, R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro. Surveill., 2008, 13, 1-11.
28. Miriagou, V.; Cornaglia, G.; Edelstein, M.; Galani, I.; Giske, C.G.; Gniadkowski, M.; Malamou-Lada, E.; Martinez-Martinez, L.; Navarro, F.; Nordmann, P.; Peixe, L.; Pournaras, S.; Rossolini, G.M.; Tsakris, A.; Vatopoulos, A.; Cantón R. Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. Clin. Microbiol. Infect., 2010, 16, 112-122.
29. Senda, K.; Arakowa, Y.; Nakashima, K.; Ito, H.; Ichiyama, S.; Shimokata, K.; Kato, N.; Ohta, M. Multifocal outbreaks of metallo-β-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum β-lactams, including carbapenems. Antimicrob. Agents Chemother., 1996, 40, 349-353.
30. Rolain, J.M.; Fancello, L.; Desnues, C.; Raoult, D. Bacteriophages as vehicles of the resistome in cystic fibrosis. J. Antimicrob. Chemother., 2011, 66, 2444-24477.
31. Fancello, L.; Desnues, C.; Raoult, D.; Rolain, J. M. Bacteriophages and diffusion of genes encoding antimicrobial resistance in cystic fibrosis sputum microbiota. J. Antimicrob. Chemother., 2011, 66, 2448-2454.
32. Weinbauer, M. G. Ecology of prokaryotic viruses. FEMS Microbiol. Rev., 2004, 28, 127-181.
33. Ackermann, H.W. 5500 Phages examined in the electron microscope. Arch. Virol., 2007, 152, 227-243.
34. Matsuzaki, S.; Rashel, M.; Uchiyama, J.; Sakurai, S.; Ujihara, T.; Kuroda, M.; Ikeuchi, M.; Tani, T.; Fujieda, M.; Wakiguchi, H.; Imai, S. Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases. J. Infect. Chemother., 2005, 11, 211-219
35. Housby, J.N.; Mann, N.H. Phage therapy. Drug Discov. Tod., 2009, 14, 536-540.
36. Górski, A.; Borysowski, J.; Miedzybrodzki, R.; Weber-Dabrowska, B. In: Genetics and Molecular Biology. Bacteriophages in medicine; S. McGrath, D. van Sinderen, Ed.; Caister Academic Press, 2007, pp. 125-158.
37. Bernhardt, T.G.; Roof, W.D.; Young, R. Genetic evidence that the bacteriophage fX174 lysis protein inhibits cell wall synthesis. Proc. Natl. Acad. Sci., 2000, 97, 4297-4302.
38. Bernhardt, T.G.; Struck, D.K.; Young, R. The lysis protein E of fX174 is a specific inhibitor of the MraY-catalyzed step in peptidoglycan synthesis. J. Biol. Chem., 2000, 276, 6093-6097.
39. Bernhardt, T.G.; Wang, I-N.; Struck, D.K.; Young, R. A protein antibiotic in the phage Qb virion: diversity in lysis target. Science, 2001, 292, 2326-2329.
40. Cao, J.; Sun, Y.; Berglindh, T.; Mellgard, B.; Li, Z.; Mardh, B.; Mardh, S. Helicobacter pylori-antigen-binding fragments expressed on the filamentous M13 phage prevent bacterial growth. Biochem. Biophys. Acta, 2000, 1474, 107-13.
41. Hagens, S.; Habel, A.; von Ahsen, U.; von Gabain, A.; Blasi, U. Therapy of experimental pseudomonas infections with a nonreplicating genetically modified phage. Antimicrob. Agents. Chemother., 2004, 48, 3817-3822.
42. Leclerc, H.; Edberg, S.; Pierzo, V.; Delattre, J.M. Bacteriophages as indicators of enteric viruses and public health risk in groundwaters. J. Appl. Microb., 2000, 88, 5-21.
43. Lenski, R.E.; Dynamics of interactions between bacteria and virulent bacteriophage. Adv. Microb. Ecol., 1988, 10, 1-44.
44. Hanlon, G. W. Bacteriophages: an appraisal of their role in the treatment of bacterial infections. Int. J. Antimicrob. Agents, 2007, 30, 118-128.
45. Guttman, B.; Raya, R.; Kutter, E. In: Basic phage biology. Bacteriophages Biology and Application;. Kutter, E.; Sulakvelidze, A. Ed.; Boca Raton, FL, USA: CRC Press, 2005; pp. 29-66.
46. Young, R.; Wang, I.N. In: The Bacteriophages; Calendar, Ed.;, Oxford University Press, New York, 2006; pp. 104-125.
47. Abedon, S. In: The Bacteriophages, Calendar, Ed, Oxford University Press, New York, 2005.
48. Gill, J.J.; Hyman, P. Phage choice, isolation, and preparation for phage therapy. Curr. Pharm. Biotechnol., 2010, 11, 2-14.
49. Merabishvili, M.; Pirnay, JP.; Verbeken, G.; Chanishvili, N.; Tediashvili, M.; Lashkhi, N.; Glonti, T.; Krylov, V.; Mast, J.; Van Parys, L.; Lavigne, R.; Volckaert, G.; Mattheus, W.; Verween, G.; De Corte, P.; Rose, T.; Jennes, S.; Zizi, M.; De Vos, D.; Vaneechoutte, M. Quality-controlled small-scale production of a welldefined bacteriophage cocktail for use in human clinical trials. PLoS One, 2009, 4, e4944.
50. Pirnay, J.P.; De Vos, D.; Verbeken, G.; Merabishvili, M.; Chanishvili, N.; Vaneechoutte, M.; Zizi, M.; Laire, G.; Lavigne, R.; Huys, I.; Van den Mooter, G.; Buckling, A.; Debarbieux, L.; Pouillot, F.; Azeredo, J.; Kutter, E.; Dublanchet, A.; Górski, A.; Adamia, R. The phage therapy paradigm: prêt-à-porter or surmesure? Pharm. Res., 2011, 28, 934-937.
51. Finberg, R.W.; Moellering, R.C.; Tally, F.P.; Craig, W.A.; Pankey, G.A.; Dellinger, E.P.; West, M.A.; Joshi, M.; Linden, P.K.; Rolston, K.V.; Rotschafer, J.C.; Rybak, M.J. The importance of bactericidal drugs: future directions in infectious disease. Clin. Infect Dis., 2004, 39, 1314-1320.
52. Ryan, EM.; Gorman, SP.; Donnelly, RF.; Gilmore, BF. Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy. J. Pharm. Pharmacol., 2011, 63, 1253-1264.
53. Abedon, S.T. Kinetics of phage-mediated biocontrol of bacteria. Foodborne. Pathog. Dis., 2009, 6, 807-815.
54. Rybak, M.J. Pharmacodynamics: relation to antimicrobial resistance. Am. J. Infect. Control, 2006, 34, 38-45.
55. Goodridge, L.D. Designing Phage Therapeutics. Curr. Pharm. Biotechnol., 2010, 11, 15-27.
56. Abedon, S.T.; Thomas-Abedon, C. Phage therapy pharmacology. Curr. Pharm. Biotechnol., 2010, 11, 28-47.
57. Kutter, E.; De Vos, D.; Gvasalia, G.; Alavidze, Z.; Gogokhia, L.; Kuhl, S.; Abedon S.T.; Phage therapy in clinical practice: Treatment of human infections. Curr. Pharm. Biotech., 2010, 11, 69-86.
58. Sihorkar, V.; Vyas, S.P. Biofilm consortia on biomedical and biological surfaces: delivery and targeting strategies. Pharmaceutic. Res., 2001, 18, 1247-1254.
59. Broxmeyer, L.; Sosnowska, D.; Miltner, E.; Chacón, O.; Wagner, D.; McGarvey, J.; Barletta, R.G.; Bermudez, L.E. Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: a model for phage therapy of intracellular bacterial pathogens. J. Infect. Dis., 2002, 186, 1155-1160.
60. Dabrowska, K.; Switaaa-Jelen, K.; Opolski, A.; Weber-Dabrowska, B.; Gorski, A. Bacteriophage penetration in vertebrates. J. Applied Microb., 2005, 98, 7-13.
61. Nungester, W.J.; Watrous, R.M. Accumulation of bacteriophage in spleen and liver following its intravenous inoculation. Proc. Soc. Exp. Biol. Med., 1934, 31, 901-905.
62. Merril, C.R.; Biswas, B.; Carlton, R.; Jensen, N.C.; Creed, G.J.; Zullo, S.; Adhya, S. Long-circulating bacteriophage as antibacterial agents. Proc. Natl. Acad. Sci. USA, 1996, 93, 3188-3192.
63. Jończyk, E.; Kaak, M.; Miedzybrodzki, R.; Górski, A. The influence of external factors on bacteriophages. Folia Mikrobiol., 2011, 56, 191-200.
64. Stern, A.; Sorek, R. The phage-host arms race: Shaping the evolution of microbes. Bioessays, 2010, 33, 43-51.
65. Makarova, K.S.; Haft, D.H.; Barrangou, R.; Brouns, S.J.; Charpentier, E.; Horvath, P.; Moineau, S.; Mojica, F.J.; Wolf, Y.I.; Yakunin, A.F.; van der Oost, J.; Koonin, E.V. Evolution and classification of the CRISPR-Cas systems. Nat Rev Microbiol., 2011, 9(6), 467-477.
66. Riede, I.; Eschbach, M.L. Evidence that TraT interacts with OmpA of Escherichia coli. FEBS Lett., 1986, 205, 241-245.
67. Nordström, K.; Forsgren, A. Effect of protein A on adsorption of bacteriophages to Staphylococcus aureus. J. Virol., 1974, 14, 198-202.
68. Liu, M.; Deora, R.; Doulatov, S.R.; Gingery, M.; Eiserling, F.A.; Preston, A.; Maskell, D.J.; Simons, R.W.; Cotter, P.A.; Parkhill, J.; Miller, J.F. Reverse transcriptase-mediated tropism switching in Bordetella bacteriophage. Science, 2002, 295, 2091-2094.
69. Kopociński, B.; Lachowicz, T.M.; Niedbach, J.; Kawa Z. Modelling of population dynamics in batch and continuos cultures of Shigella flexneri 3b serovar lysogenic for a plaque-less phage, and Shigella flexneri 1b serovar which is sensitive to it. Cell. Mol. Biol. Lett., 1997, 2, 265-276.
70. Letarov, A.; Kulikov, E.; The bacteriophages in human-and animal body-associated microbial communities. J. Appl. Microbiol., 2009, 107, 1-13.
71. Connerton, P.L.; Timms, A.R.; Connerton, I.F. Campylobacter bacteriophages and bacteriophage therapy. J. Applied. Microb., 2011, 111, 255-265.
72. Weinbauer, M. G.; Rassoulzadegan, F. Are viruses driving microbial diversification and diversity? Environ. Microbiol. 2004, 6, 1-11.
73. Lu, T.K.; Koeris, M.S. The next generation of bacteriophage therapy. Curr. Opinion Microbiol., 2011, 14, 524-531.
74. Capparelli, R.; Parlato, M.; Borriello, G.; Salvatore, P.; Iannelli, D. Experimental phage therapy against Staphylococcus aureus in mice. Antimicrob. Agents Chemother., 2007, 51, 2765-2773.
75. O'Flynn, G.; Ross, RP.; Fitzgerald, GF.; Coffey, A. Evaluation of a cocktail of three bacteriophages for biocontrol of Escherichia coli O157:H7. Appl. Environ. Microbiol., 2004, 70, 3417-3424.
76. Pelkonen, S.; Aalto, J.; Finne, J. Differential activities of bacteriophage depolymerase on bacterial polysaccharide: binding is essential but degradation is inhibitory in phage infection of K1-defective Escherichia coli. J. Bacteriol., 1992, 174, 7757-7761.
77. Nimmich, W. Detection of Escherichia coli K95 strains by bacteriophages. J. Clin. Microbiol., 1994, 32, 2843-2845.
78. Linnerborg, M.; Weintraub, A.; Albert, M.J.; Widwalm, G. Depolymerization of the capsular polysaccharide from Vibrio cholerae O139 by a lyase associated with the bacteriophage JA1. Carbohydrate Res., 2001, 333, 263-269.
79. Castillo, F.J.; Bartell, P.F. Localization and functional role of the Pseudomonas bacteriophage 2 depolymerase. J. Virol., 1976, 18, 701-708.
80. Hughes, K.A.; Sutherland, I.W.; Clark, J.; Jones, M.V. Bacteriophage and associated polysaccharide depolymerases-novel tools for study of bacterial biofilms. J. Appl. Microbiol., 1998, 85, 583-590.
81. Cornelissen, A.; Ceyssens P.J.; T'Syen J.; Van Praet, H.; Noben, J.P.; Shaburova, O.V.; Krylov, V.N.; Volckaert, G.; Lavigne, R. The T7-related Pseudomonas putida phage β15 displays virionassociated biofilm degradation properties. PLoS ONE, 2011, 6, e18597.
82. Donlan, R.M. Preventing biofilms of clinically relevant organisms using bacteriophage. Trends Microbiol., 2009, 17, 66-72.
83. Sutherland, I.W.; Hughes, K.A.; Skillman, L.C.; Tait, K. The interaction of phage and biofilms. FEMS Microbiol. Lett., 2004, 232, 1-6.
84. Sutherland, I.W. Polysaccharases for microbial exopolysaccharides. Carbohydr. Polym., 1999, 38, 319-328.
85. Yurewicz, E.C.; Ghalambor, M.A.; Duckworth, D.H.; Heath, E.C. Catalytic and molecular properties of a phage induced capsular polysaccharide depolymerase. J. Biol. Chem., 1971, 246, 5607-5616.
86. Stirm, S.; Freund-Mölbert, E. Escherichia coli capsule bacteriophages. II. Morphology. J. Virol., 1971, 8, 330-342.
87. Gross, R.J.; Cheasty, T.; Rowe, B. Isolation of bacteriophages specific for the K1 polysaccharide antigen of Escherichia coli. J. Clin. Microbiol., 1977, 6, 548-550.
88. Kwiatkowski, B.; Boschek, B.; Thiele, H.; Stirm, S. Endo-Nacetylneuraminidase associated with bacteriophage particles. J. Virol., 1982, 43, 697-704.
89. Smith, H.W.; Huggins, M.B. Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. J. Gen. Microbiol., 1982, 128, 307-318.
90. Kwiatkowski, B.; Boschek, B.; Thiele, H.; Stirm, S. Substrate specificity of two bacteriophage-associated endo-Nacetylneiraminidases. J. Virol., 1983, 45, 367-374.
91. Vimr, E.R.; McCoy, R.D.; Vollger, H.F.; Wilkison, N.C.; Troy, F.A. Use of prokaryotic-derived probes to identify poly(sialic acid) in neonatal neuronal membranes. Proc. Natl. Acad. Sci. USA, 1984, 81, 1971-1975.
92. Miyake, K.; Muraki T.; Hattori K.; Machida, Y.; Watanable, M.; Kawase, M.; Yoshida, Y.; Iijima, S. Screening of bacteriophages producing endo-N-acetylneuraminidase. J. Ferm. Bioeng., 1997, 84, 90-93.
93. Scholl, D.; Rogers, S.; Adhya, S.; Merril, C.R. Bacteriophage K1-5 encodes two different tail fiber proteins, allowing it to infect and replicate on both K1 and K5 strains of Escherichia coli. J. Virol., 2001, 75, 2509-2515.
94. Deszo, E.L.; Steenbergen, S.M.; Freedberg, D.I.; Vimr, E.R. Escherichia coli K1 polysialic acid O-acetyltransferase gene, neuO, and the mechanism of capsule form variation involving a mobile contingency locus. Proc. Natl. Acad. Sci. USA, 2005, 102, 5564-5569.
95. Jakobsson, E.; Jokilammi, A.; Aalto, J.; Ollikka, P.; Lehtonen, J.V.; Hirvonen, H.; Finne, J. Identification of amino acid residues at the active site of endosialidase that dissociate the polysialic acid binding and cleaving activities in Escherichia coli K1 bacteriophages. Biochem. J., 2007, 405, 465-472.
96. Gerardy-Schahn, R.; Bethe, A.; Brennecke, T.; Mühlenhoff, M.; Eckhardt, M.; Ziesing, S.; Lottspeich, F.; Frosch, M. Molecular cloning and functional expression of bacteriophage PK1E-encoded endoneuraminidase EndoNE. Mol. Microbiol., 1995, 16, 441-450.
97. Long, G.S.; Bryant, J.M.; Taylor, P.W.; Luzio, J.P. Complete nucleotide sequence of the gene encoding bacteriophage E endosialidase: implications for K1E endosialidase structure and function. Biochem. J., 1995, 309, 543-550.
98. Peter, J.G.; Vimr, E.R. Complete nucleotide sequence of the bacteriophage K1F tail gene encoding endo-N-acetylneuraminidase (endo-N) and comparison to an endo-N homolog in bacteriophage PK1E. J. Bacterial., 1993, 175, 4354-4363.
99. Mühlenhoff, M.; Stummeyer, K.; Grove, M.; Sauerborn, M.; Gerardy-Schahn, R. Proteolytic processing and oligomerization of bacteriophage-derived endosialidases. J. Biol. Chem., 2003, 278, 12634-12644.
100. Machida, Y.; Miyake, K.; Hattori, K.; Yamamoto, S.; Kawase, M.; Iijima, S. Structure and function od a novel coliphage-associated sialidase. FEMS Microbiol. Lett., 2000, 182, 333-337.
101. Stummeyer, K.; Schwarzer, D.; Claus, H.; Vogel, U.; Gerardy-Schahn, R.; Mühlenhoff, M. Evolution of bacteriophages infecting encapsulated bacteria: lessons from Escherichia coli K1-spesific phages. Mol. Microbiol., 2006, 60, 1123-1135.
102. Bartell, P.F.; Orr, T.E.; Lam, G.K.L. Purification and properties of polysaccharide depolymerase associated with phage-infected Pseudomonas aeruginosa. J. Biol. Chem., 1968, 243, 2077-2080.
103. Shaburowa, O.V.; Krylov, S.V.; Veiko, V.P.; Pleteneva, E.A.; Burkal'tseva, M.V.; Miroshnikov, K.A.; Cornelissen, A.; Lavigne, R.; Sykilinda, N.N., Kadykov, V.A.; Mesyanzhinov, V.V.; Volckaert, G.; Krylov, V.N. Search for destruction factors of bacterial biofilms: comparison of phage properties in a group of Pseudomonas putida bacteriophages and specificity of their haloformation products. Russian J. Gen., 2009, 45, 185-195.
104. Glonti, T.; Chanishvili, N.; Taylor, P.W. Bacteriophage-derived enzyme that depolymerizes the alginic acid capsule associated with cystic fibrosis isolates of Pseudomonas aeruginosa. J. Appl. Microbiol., 2010, 108, 695-702.
105. Pleteneva, E.A.; Bourkaltseva, M.V.; Shaburowa, O.V.; Krylov, S.V.; Pechnikova, E.V.; Sokolova, O.S.; Krylov, V.N. TL, The new bacteriophage of Pseudomonas aeruginosa and its application for the search of halo-producing bacteriophages. Russian J. Gen., 2011, 47, 1-5.
106. Sutherland, I.W. Highly specific bacteriophage-associated polysaccharide hydrolases for Klebsiella aerogenes type 8. J. Gen. Microbiol., 1976, 94, 211-216.
107. Rieger-Hug, D.; Stirm, S. Comparative study of host capsule depolymerases associated with Klebsiella bacteriophages. Virology, 1981, 113, 363-378.
108. Verma, V.; Harjai, K.; Chhibber, S. Characterization of T7-like lytic bacteriophage of Klebsiella pneumoniae B5055: a potential therapeutic agents. Curr. Microbiol., 2009, 59, 274-281.
109. Verma, V.; Harjai, K.; Chhibber, S. Restricting ciprofloxacininduced resistant variant formation in biofilm of Klebsiella pneumoniae B5055 by complementary bacteriophage treatment. J. Antimicrob. Chemiother., 2009, 64, 1212-1218.
110. Verma, V.; Harjai, K.; Chhibber, S. Structural changes induced by a lytic bacteriophage make ciprofloxacin effective against older biofilm of Klebsiella pneumoniae. Biofouling, 2010, 26, 729-737.
111. Kassa, T.; Chhibber, S. Thermal treatment of the bacteriophage lysate of Klebsiella pneumoniae B5055 as a step for the purification of capsular depolymerase enzyme. J. Virol. Methods, 2012, 179, 135-141.
112. Baker, J.R.; Dong, S.; Pritchard, D.G. The hyaluronan lyase of Streptococcus pyogenes bacteriophage H4489A. Biochem. J., 2002, 365,317-322.
113. Hynes, W.L.; Hancock, L.; Ferretti, J.J. Analysis of a second bacteriophage hyaluronidase gene from Streptococcus pyogenes: evidence for a third hyaluronidase involved in extracellular enzymatic activity. Infect. Immun., 1995, 63, 3015-3020.
114. Mishra, P.; Akhtar, S.; Bhakuni, V. J. Unusual structural features of the bacteriophage-associated hyaluronate lyase (hylp2). J. Biol. Chem., 2006, 281, 7143-7150.
115. Martinez-Fleites, C.; Smith, N.L.; Turkenburg, J.P.; Black, G.W.; Taylor, E.J. Structures of two truncated phage-tail hyaluronate lyases from Streptococcus pyogenes serotype M1. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun., 2009, 65, 963-966.
116. Ferretti, J.J.; McShan, W.M.; Ajdic, D.; Savic, D.J.; Lyon, K.; Primeaux, C.; Sezate, S.; Suvorov, A.N.; Kenton, S.; Lai, H.S.; Lin, S.P.; Qians, Y.; Jia, H.G.; Najar, F.Z.; Ren, Q.; Zhu, H.; Song, L.; White, J.; Yuan, X.; Clifton, S.W.; Roe, B.A.; McLaughlin, R. Complete genome sequence of an M1 strain of Streptococcus pyogenes. PNAS, 2001, 98, 4658-4663.
117. Lindsay, A.M.; Zhang, M.; Mitchell, Z.; Holden, M.T.; Waller, A.S.; Sutcliffe, I.C.; Black, G.W. The Streptococcus equi prophage-encoded protein SEQ2045 is a hyaluronan-specific hyaluronate lyase that is produced during equine infection. Microbiology, 2009,155, 443-9.
118. Lee, J.H.; Moore, L.D.; Kumar, S.; Pritchard, D.G.; Ponnazhagan, S.; Deivanayagam, C. Bacteriophage hyaluronidase effectively inhibits growth, migration and invasion by disrupting hyaluronanmediated Erk1/2 activation and RhoA expression in human breast carcinoma cells. Cancer Lett., 2010, 298, 238-249.
119. Sertic, V. 'Origine de la lysine d'une race du bacteriophage'.C. R. Soc. Biol. (Paris), 1929, 100, 477.
120. Tait, K.; Skillman, L.C.; Sutherland, I.W. The efficacy of bacteriophage as a model of biofilm eradication. Biofouling, 2002, 18, 305-311.
121. Hughes, K.A; Sutherland, I.W.; Clark, J.; Jones, M.V. Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase. Microbiology, 1998, 144, 3039-3047.
122. Hanlon, G.W.; Denyer, S.P.; Olliff, C.J.; Ibrahim, L.J. Reduction in exopolysaccharide viscocity as an aid to bacteriophage penetration through Pseudomonas aeruginosa biofilms. Appl. Environ. Microbiol., 2001, 67, 2746-2753.
123. Sutherland, I.W. Polysaccharide lyases. Carbohydr. FEMS Microbiol. Rev., 1995, 16, 323-347.
124. Thompson, J.E.; Pourhossein, M.; Waterhouse, A.; Hudson, T.; Goldrick, M.; Derrick, J.P.; Roberts, I.S. The K5 lyase KflA combines a viral tail spike structure with a bacterial polysaccharide lyase mechanizm. J. Biol. Chem., 2010, 285, 23693-23969.
125. Azeredo, J.; Sutherland, I.W. The use of phages for the removal of infections biofilms. Curr. Pharmaceutical Biotechnol., 2008, 9, 261-266.
126. Alemayehu, D.; Casey, P.G.; McAuliffe, O.; Guinane, C.M.; Martin, J.G.; Shanahan, F.; Coffey, A.; Ross, R.P.; Hill, C. Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells. mBio, 2012, 3(2), e00029-e00312.
127. Lu, T.K.; Collins, J.J. Dispersing biofilms with engineered enzymatic bacteriophage. Proc. Natl. Acad. Sci. USA, 2007, 104, 11197-11202.
128. Collins, J.J.; Lu, T.K. Engineered enzymatically active bacteriophages and methods for dispersing biofilms. U.S. Patent 8, 153, 119 B2, April 10, 2008.
129. Itoh, Y.; Wang, X.; Hinnesbusch, B.J.; Preston, J.F.; Romeo, T. Depolymerization of β-1,6-N-acetyl-D-glucosamine disrupts the integrity of diverse bacterial biofilms. J. Bacteriol., 2005, 187, 382-7.
130. Walker, S.L.; Fourgialakis, M.; Cerezo, B.; Livens, S. Removal of microbial biofilms from dispense equipment: the effect of enzymatic pre-digestion and detergent treatment. Journal of the Institute of Brewing, 2007, 113, 61-66.
131. Merril, C.R.; Scholl, D.; Adhya, S.L. The prospect for bacteriophage therapy in Western medicine. Nat. Rev. Drug Discov., 2003, 2, 489-497.
132. Lu, T.K.; Collins, J.J. Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy. Proc. Natl. Acad. Sci. USA, 2009, 106, 4629-4634.
133. Alkawash, M.A.; Soothill, J.S.; Schiller, N.L. Alginate lyase enhances antibiotic killing of mucoid Pseudomonas aeruginosa in biofilms. APMIS, 2006, 114, 131-138.
134. Kim, W.S.; Geider, K. Characterization of a viral EPSdepolymerase, a potential tool for control of fire blight. Phytopathology, 2000, 90, 1263-1268.
135. Mushtaq, N.; Redpath, M.B.; Luzio, J.P.; Taylor, P.W. Treatment of experimental Escherichia coli infection with recombinant bacteriophage-derived capsule depolymerase. J. Antimicrob. Chemother., 2005, 56, 160-165.
136. Martin, M.J.; Gundogdu, O.; Birchenough, G.; Lever, R. Wren, B.W.; Luzio, J.P.; Taylor, P.W. Administration of capsule-selective endosialidase E minimizes upregulation of organ gene expression induced by experimental systemic infection with Escherichia coli K1. Microbiology, 2010, 156, 2205-2215.
137. Scorpio, A.; Tobery, S.A.; Ribot, W.J.; Friedlander, A.M. Treatment of experimental anthrax with recombinant capsule depolymerase. Antimicrob. Agents Chemother., 2008, 52, 1014-1020.
138. Scorpio, A.; Chabot, D.J.; Day, W.A.; Hoover, T.A.; Friedlander, A.M. Capsule depolymerase overexspression reduces Bacillus anthracis virulence. Microbiology, 2010, 156, 1459-1467.
139. Altmann, F.; Christian, R.; Czerny, T.; Nimmich, W.; März, L. Bacteriophage-associated glycan hydrolases specific for Escherichia coli capsular serotype K12. Eur. J. Biochem., 1990, 189, 307-312.
140. Rutishauser, U. Polysialic acid and the regulation of cell interactions. Curr. Opin. Cell Biol., 1996, 8, 679-684.
141. Tanaka, F.; Otake, Y.; Nakagawa, T.; Kawano, Y.; Miyahara, R.; Li, M.; Yanagihara, K.; Nakayama, J.; Fujimoto, I.; Ikenaka, K.; Wada, H. Expression of polysialic acid and STX, a human polysialyltransferase, is correlated with tumor progression in non-small cell lung cancer. Cancer Res., 2000, 60, 3072-3080.
142. Oltmann-Norden, I.; Galuska, S.P.; Hildebrandt, H.; Geyer, R.; Gerardy-Schahn, R.; Geyer, H.; Muhlenhoff, M. Impact of the polysialyltransferases ST8SiaII and ST8SiaIV on polysialic acid synthesis during postnatal mouse brain development. J. Biol. Chem., 2008, 283, 1463-1471.
143. Berski, S.; van Bergeijk, J.; Schwarzer, D.; Stark, Y.; Kasper, C.; Scheper, T.; Grothe, C.; Gerardy-Schahn, R.; Kirschning, A.; Dräger G. Synthesis and biological evaluation of a polysialic acidbased hydrogel as enzymatically degradable scaffold material for tissue engineering. Biomacromolecules, 2008, 9, 2353-2359.
144. Jakobsson, E.; Schwarzer, D.; Jokilammi, A.; Finne Y. Endosialidases: Versatile Tools for the Study of Polysialic Acid. Top. Curr. Chem., 2012, Aug 1, DOI: 10.1007/128_2012_349.
145. Roucourt, B.; Lavigne, R. The role of interactions between phage and bacterial proteins within the infected cell: a diverse and puzzling interactome. Environ. Microbiol., 2009, 11, 2789-2805.
146. Miller, E.S.; Kutter, E.; Mosig, G.; Arisaka, F.; Kunisawa T.; Ruger, W. Bacteriophage T4 genome. Microbiol. Mol. Biol. Rev., 2003, 67, 186-156.
147. Liu, J.; Dehbi, M.; Moeck, G.; Arhin, F.; Bauda, P.; Bergeron, D.; Callejo, M.; Ferretti, V.; Ha, N.; Kwan, T.; McCarty, J.; Srikumar, R.; Williams, D.; Wu, J.J.; Gros, P.; Pelletier, J.; DuBow M. Antimicrobial drug discovery through bacteriophage genomics. Nat. Biotechnol., 2004, 22, 185-191.
148. Mueser, T.C.; Hinerman, J.M.; Devos, J.M.; Boyer R.A.; Williams K.J. Structural analysis of bacteriophage T4 DNA replication: a review in the Virology Journal series on bacteriophage T4 and its relatives. Virol.J., 2010, 7, 359.
149. Friedman, D.I.; Olson, E.R.; Georgopoulos, C.; Tilly, K.; Herskowitz, I.; Banuett, F. Interactions of bacteriophage and host macromolecules in the growth of bacteriophage lambda. Microbiol. Rev., 1984, 48, 299-325.
150. Mallory, J.B.; Alfano, C.; McMacken, R. Host virus interactions in the initiation of bacteriophage lambda DNA replication. Recruitment of Escherichia coli DnaB helicase by lambda P replication protein. J. Biol. Chem., 1990, 265, 13297-13307.
151. Nechaev, S.; Severinov, K. Bacteriophage-induced modifications of host RNA polymerase. Annu. Rev. Microbiol., 2003, 57, 301-322.
152. Sau, S.; Chattoraj, P.; Ganguly, T.; Chanda, P.K.; Mandal, N.C. Inactivation of indispensable bacterial proteins by early proteins of bacteriophages: implication in antibacterial drug discovery. Curr. Protein Pept. Sci., 2008, 9, 284-290.
153. Pavlova, O.; Lavysh, D.; Klimuk, E.; Djordjevic, M.; Ravcheev, D.A.; Gelfand, M.S.; Severinov, K.; Akulenko, N. Temporal regulation of gene expression of the Escherichia coli bacteriophage phiEco32. J. Mol. Biol., 2012, 416, 389-399.
154. Nechaev, S.; Severinov, K. The elusive object of desire--interactions of bacteriophages and their hosts. Curr. Opin. Microbiol., 2008, 11, 186-193.
155. Grill, S.; Moll, I.; Hasenohrl, D.; Gualerzi, C.O.; Blasi, U. Modulation of ribosomal recruitment to 5'-terminal start codons by translation initiation factors IF2 and IF3. FEBS Lett., 2001, 495, 167-171.
156. Sevostyanova, A.; Djordjevic, M.; Kuznedelov, K.; Naryshkina, T.; Gelfand, M.S.; Severinov, K.; Minakhin, L. Temporal regulation of viral transcription during development of Thermus thermophilus bacteriophage phiYS40. J. Mol. Biol., 2007, 366, 420-435.
157. Goldfarb, A.; Palm, P. Control of promoter utilization by bacteriophage T4-induced modification of RNA polymerase alpha subunit. Nucleic. Acids Res., 1981, 9, 4863-4878.
158. Depping, R.; Lohaus C.; Meyer H.E.; Ruger W. The mono-ADPribosyltransferases Alt and ModB of bacteriophage T4: target proteins identified. Biochem. Biophys. Res. Commun., 2005, 335, 1217-1223.
159. Semerjian, A.V.; Malloy, D.C.; Poteete, A.R. Genetic structure of the bacteriophage P22 PL operon. J. Mol. Biol., 1989, 207, 1-13.
160. Waggoner, B.T.; Sultana, K.; Symonds, N.; Karlok, M.A.; Pato, M.L. Identification of the bacteriophage Mu kil gene. Virology, 1989, 173, 378-389.
161. Conter, A.; Bouche, J.P.; Dassain, M. Identification of a new inhibitor of essential division gene ftsZ as the kil gene of defective prophage. Rac. J. Bacteriol., 1996, 178, 5100-5104.
162. Sergueev, K.; Yu, D.; Austin, S.; Court, D. Cell toxicity caused by products of the p(L) operon of bacteriophage lambda. Gene, 2001, 272, 227-235.
163. Casjens, S.D.; Winn-Stapley, A.; Gilcrease, E.B.; Morona, R.; Kuhlewein, C.; Chua, J.E.; Manning, P.A.; Inwood, W.; Clark, A.J. The chromosome of Shigella flexneri bacteriophage Sf6: complete nucleotide sequence, genetic mosaicism, and DNA packaging. J. Mol. Biol., 2004, 339, 379-394.
164. Young, R.; Wang, I.N.; Roof, W.D. Phages will out: strategies of host cell lysis. Trends Microbiol., 2000, 8, 120-128.
165. Summer, E.J.; Berry, J.; Tran, T.A.; Niu, L.; Struck, D.K.; Young, R.J. Rz/Rz1 lysis gene equivalents in phages of Gram-negative hosts. Mol. Biol., 2007, 373, 1098-1112.
166. Briers, Y.; Peeters, L.M.; Volckaert G.; Lavigne, R. The lysis cassette of bacteriophage βKMV encodes a signal-arrest-release endolysin and a pinholin bacteriophage lysis: mechanism and regulation. Bacteriophage, 2011, 1, 25-30.
167. Kakikawa, M. Molecular analysis of the lysis protein Lys encoded by Lactobacillus plantarum phage (c)g1e. Gene, 2002, 299, 227-234.
168. Xu, M.; Struck, D.; Deaton, J.; Wang, I.N.; Young, R. A signalarrest-release sequence mediates export and control of the phage P1 endolysin. Proc. Natl. Acad. Sci. USA, 2004, 101, 6415-6420.
169. Nascimento, J.G.; Guerreiro-Pereira, M.C.; Costa, S.F.; C. São-José, C.; Santos, M.A. Nisin-triggered activity of Lys44, the secreted endolysin from Oenococcus oeni phage fOg44. J. Bacteriol., 2008, 190, 457-461.
170. Loessner, M.J.; Wendlinger, G.; Scherer, S. Heterogeneous endolysins in Listeria monocytogenes bacteriophages: a new class of enzymes and evidence for conserved holin genes within the siphoviral lysis cassettes. Mol. Microbiol., 1995, 16, 1231-1241.
171. Loessner, M.J.; Maier, S.K.; Daubek-Puza, H.; Wendlinger, G.; Scherer, S. Three Bacillus cereus bacteriophage endolysins are unrelated but reveal high homology to cell wall hydrolases from different bacilli. J. Bacteriol., 1997, 179, 2845-2851.
172. Cloutier, I.; Paradis-Bleau, C.; Giroux, A.M.; Pigeon, X.; Arseneault, M.; Levesque, R.C.; Auger, M. Biophysical studies of the interactions between the phage varphiKZ gp144 lytic transglycosylase and model membranes. Eur. Biophys. J., 2010, 39, 263-276.
173. Bernhardt, T.G.; Wang, I.N.; Struck, D.K.; Young, R. Breaking free: protein antibiotics and phage lysis. Res.Microbiol., 2002, 153, 493-501.
174. Callewaert, L.; Walmagh, M.; Michiels, CW.; Lavigne R. Food applications of bacterial cell wall hydrolases. Curr. Opin Biotechnol., 2011, 22, 164-171.
175. Fischetti, V.A. Bacteriophage lytic enzymes: novel anti-infectives. Trends Microbiol., 2005, 13, 491-496.
176. Borysowski J.; Weber-Dabrowska B.; Górski A. Bacteriophage endolysins as a novel class of antibacterial agents. Exp Biol Med., 2006, 231, 366-377.
177. http://ebm.rsmjournals.com/content/231/4/366.full-target-1 Nelson, D.; Schuch, R.; Chahales, P.; Zhu, S.; Fischetti, V.A. PlyC: a multimeric bacteriophage lysin. Proc. Natl. Acad. Sci. USA, 2006, 103, 10765-10770.
178. Briers, Y.; Volckaert, G.; Cornelissen, A.; Lagaert, S.; Michiels, C.W.; Hertveldt, K.; Lavigne, R.; Muralytic activity and modular structure of the endolysins of Pseudomonas aeruginosa bacteriophages phiKZ and EL. Molecular Microbiology, 2007, 65, 1334-1344.
179. Payne, K.M.; Hatfull, G.F.; Mycobacteriophage endolysins: Diverse and modular enzymes with multiple catalytic activities, PLoS ONE, 2012, 7, e34052.
180. Becker, S.C.; Dong, S.; Baker, J.R.; Foster-Frey, J.; Pritchard, D.G.; Donovan, D.M. LysK CHAP endopeptidase domain is required for lysis of live staphylococcal cells. FEMS Microbiol Lett., 2009, 294, 52-60.
181. Walmagh, M.; Boczkowska, B.; Gymonprez, B.; Briers, Y.; Drulis-Kawa, Z.; Lavigne, R. Characterization of five novel endolysins from Gram-negative infecting bacteriophages. Appl. Microbiol. Biotech., 2012, DOI: 10.1007/s00253-012-4294-7.
182. Walmagh M, Briers, Y.; dos Santos, S.B.; Azeredo, J.; Lavigne, R.; Characterization of modular bacteriophage endolysins from Myoviridae phages OBP, 201φ2-1 and PVP-SE1. PLoS ONE, 2012, 7, e36991.
183. Hermoso, J.A.; García, J.L.; García P. Taking aim on bacterial pathogens: from phage therapy to enzybiotics. Curr. Opin. Microbiol., 2007, 10, 461-472.
184. Vollmer, W.; Joris, B.; Charlier, P.; Foster, S. Bacterial peptidoglycan (murein) hydrolases, Microb. Rev., 2008, 32, 259-286.
185. Navarre, W.W.; Ton-That, H.; Faull, K.F.; Schneewind, O. Multiple enzymatic activities of the murein hydrolase from staphylococcal phage phi11. Identification of a D-alanyl-glycine endopeptidase activity. J. Biol. Chem., 1999, 274, 15847-15856.
186. Catalão, M.J.; Gil, F.; Moniz-Pereira, J.; Pimentel, M. A second endolysin gene is fully embedded in-frame with the lysA gene of mycobacteriophage Ms6. PLoS One, 2011, 6, e20515.
187. Loessner, M.J.; Kramer, K.; Ebel, F.; Scherer, S. C-terminal domains of Listeria monocytogenes bacteriophage murein hydrolases determine specific recognition and high-affinity binding to bacterial cell wall carbohydrates. Mol. Microbiol., 2002, 44, 335-349.
188. Kretzer, J.W.; Lehmann, R.; Schmelcher, M.; Banz, M.; Kim, K.P.; Korn, C.; Loessner, M.J. Use of high-affinity cell wallbinding domains of bacteriophage endolysins for immobilization and separation of bacterial cells. Appl. Environ. Microbiol., 2007, 73,1992-2000.
189. Freimer, E.H.; Krause, R.M.; McCarthy, M. Studies of L forms and protoplasts of group A streptococci. J. Exp. Med., 1959, 110, 853-874.
190. Nelson, D.; Loomis, L.; Fischetti, V.A. Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. Proc. Natl. Acad. Sci. USA, 2001, 98, 4107-4112.
191. Loeffler, J.M.; Nelson, D. Fischetti, V.A. Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science, 2001, 294, 2170-2172.
192. Loeffler, J.M.; Djurkovic, S.; Fischetti, V.A. Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia. Infect. Immun., 2003, 71, 6199-6204.
193. Yoong, P.; Schuch, R.; Nelson, D.; Fischetti, V.A. Identification of a broadly active phage lytic enzyme with lethal activity against antibiotic-resistant Enterococcus faecalis and Enterococcus faecium. J. Bacteriol., 2004, 186, 4808-4812.
194. Deutsch, S.M.; Guezenec, S.; Piot, M.; Foster, S.; Lortal, S. Mur-LH.; the broad-spectrum endolysin of Lactobacillus helveticus temperate bacteriophage f-0303. Appl. Environ. Microbiol., 2004, 70, 96-103.
195. Schuch, R.; Nelson, D.; Fischetti, V.A. Identification of a bacteriolytic agent that can rapidly and specifically detect and kill Bacillus anthracis. Nature, 2002, 418, 884-889.
196. Cheng, Q.; Nelson, D.; Zhu, S.; Fischetti, V.A. Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme. Antimicrob. Agents. Chemother., 2005, 49, 111-117.
197. Wang, J., Hu, B.; Xu, M.; Yan, Q.; Liu, S.; Zhu, X.; Sun, Z.; Tao, D.; Ding, L.; Reed, E.; Gong, J.; Li, Q.Q.; Hu, J. Therapeutic effectiveness of bacteriophages in the rescue of mice extender spectrum β-lactamase-producing Escherichia coli bacteriemia; Int. J. Mol. Med., 2006, 17, 347-355.
198. Rashel, M.; Uchiyama, J.; Ujihara, T.; Uehara, Y.; Kuramoto, S.; Sugihara, S.; Yagyu, K.; Muraoka, A.; Sugai, M.; Hiramatsu, K.; Honke, K.; Matsuzaki, S. Efficient elimination of multidrugresistant Staphylococcus aureus by cloned lysin derived from bacteriophage phi MR11. J. Infect. Dis., 2007, 196, 1237-1247.
199. Daniel, A.; Euler, C.; Collin, M.; Chahales, P.; Gorelick, K. J.; Fischetti, V.A. Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus. Antimicrob. Agents. Chemother., 2010, 54, 1603-1612.
200. Gu, J.; Zuo, J.; Lei, L.; Zhao, H.; Sun, C.; Feng, X.; Du, C.; Li, X.; Yang, Y.; Han, W. LysGH15 reduces the inflammation caused by lethal methicillin-resistant Staphylococcus aureus infection in mice. Bioeng. Bugs., 2011, 2, 96-99.
201. Young, R. Bacteriophage lysis: Mechanism and regulation. Microbiol. Rev., 1992, 56, 430-481.
202. Young, R. Bacteriophage holins: Deadly diversity. J. Mol. Microbiol. Biotechnol. 2002, 4, 21-36.
203. Tran, T.A.T.; Struck, D.K., Young, R. Periplasmic domains define holin-antiholin interactions in T4 lysis inhibition. J. Bacteriol., 2005, 187, 6631-6640.
204. Fenton, M.; Ross, P.; McAuliffe, O.; O'Mahony, J.; Coffey, A. Recombinant bacteriophage lysins as antibacterials. Bioeng. Bugs., 2010, 1, 9-16.
205. Wang, IN.; Smith, DL.; Young R. Holins: the protein clocks of bacteriophage infections. Annu. Rev. Microbiol., 2000, 54, 799-825.
206. Clarke, B.R, Esumeh, F.; Roberts, I.S. Cloning, expression, and purification of the K5 capsular polysaccharide lyase (KflA) from coliphage K5A: Evidence for two distinct K5 lyase enzymes. J. Bacteriol., 2000, 182, 3761-3766.
207. Legoux, R.; Lelong, P.; Jourde, C.; Feuillerat, C.; Capdevielle, J.; Sure, V.; Ferran, E.; Kaghad, M.; Delpech, B.; Shire, D.; Ferrara, P.; Loison, G.; Salome, M. N-acetyl-heparosan lyase of Escherichia coli K5: gene cloning and expression. J. Bacterial., 1996, 178, 7260-7264.
208. Davidson, I.W.; Lawson, C.J.; Sutherland, I.W. An alginate lysate from Azotobacter vinelandii phage. J. Gen. Microbiol., 1977, 98, 223-239.
209. Kobiler, O.; Rokney, A.; Oppenheim, A.B. Phage lambda CIII: a protease inhibitor regulating the lysis-lysogeny decision. PLoS One, 2007, 2, e363.
210. Court, R.; Cook, N.; Saikrishnan K.; Wigley, D. The crystal structure of lambda-Gam protein suggests a model for RecBCD inhibition. J. Mol. Biol., 2007, 371, 25-33.
211. Yano, S.T.; Rothman-Denes, L.B. A phage-encoded inhibitor of Escherichia coli DNA replication targets the DNA polymerase clamp loader. Mol. Microbiol., 2011, 79, 1325-1338.
212. Michalewicz, J.; Nicholson, A.W. Molecular cloning and expression of the bacteriophage T7 0.7 (protein kinase) gene. Virology, 1992, 186, 452-462.
213. Severinova, E.; Severinov, K. Localization of the Escherichia coli RNA polymerase beta' subunit residue phosphorylated by bacteriophage T7 kinase Gp0.7. J. Bacteriol. 2006, 188, 3470-3476.
214. Mayer, J.E.; Schweiger, M. RNase III is positively regulated by T7 protein kinase. J. Biol. Chem., 1983, 258, 5340-5343.
215. Marchand, I.; Nicholson, A.W.; Dreyfus, M. Bacteriophage T7 protein kinase phosphorylates RNase E and stabilizes mRNAs synthesized by T7 RNA polymerase. Mol. Microbiol., 2001, 42, 767-776.
216. Nechaev, S; Severinov, K. Inhibition of Escherichia coli RNA polymerase by bacteriophage T7 gene 2 protein. J. Mol. Biol., 1999, 289, 815-826.
217. Kashlev, M.; Nudler, E.; Goldfarb, A.; White, T.; Kutter, E. Bacteriophage T4 Alc protein: a transcription termination factor sensing local modification of DNA. Cell, 1993, 75, 147-154.
218. Skorko, R.; Zillig, W.; Rohrer, H.; Fujiki, H.; Mailhammer, R. Purification and properties of the NAD+: protein ADPribosyltransferase responsible for the T4-phage-induced modifica tion of the alpha subunit of DNA-dependent RNA polymerase of Escherichia coli. Eur. J. Biochem., 1977, 79, 55-66.
219. Ouhammouch, M.; Adelman, K.; Harvey, S.R.; Orsini, G.; Brody, E.N. Bacteriophage T4 MotA and AsiA proteins suffice to direct Escherichia coli RNA polymerase to initiate transcription at T4 middle promoters. Proc. Natl. Acad. Sci. U S A, 1995, 92, 1451-1455.
220. Kolesky, S.; Ouhammouch, M.; Brody, E.N.; Geiduschek E.P. Sigma competition: the contest between bacteriophage T4 middle and late transcription. J. Mol. Biol., 1999, 291, 267-281.
221. Mosig, G.; Colowick, N.E.; Pietz, B.C. Several new bacteriophage T4 genes, mapped by sequencing deletion endpoints between genes 56 (dCTPase) and dda (a DNA-dependent ATPase-helicase) modulate transcription. Gene, 1998, 223, 143-155.
222. Mason, S.W.; Greenblatt, J. Assembly of transcription elongation complexes containing the N protein of phage lambda and the Escherichia coli elongation factors NusA, NusB, NusG, and S10. Genes Dev., 1991, 5, 1504-1512.
223. Marr, M.T.; Datwyler, S.A.; Meares, C.F.; Roberts, J.W. Restructuring of an RNA polymerase holoenzyme elongation complex by lambdoid phage Q proteins. Proc. Natl. Acad. Sci. U S A, 2001, 98, 8972-8978.
224. Wood, L.F.; Tszine N.Y.; Christie, G.E. Activation of P2 late transcription by P2 Ogr protein requires a discrete contact site on the C terminus of the alpha subunit of Escherichia coli RNA polymerase. J. Mol. Biol., 1997, 274, 1-7.
225. Wei, P.; Stewart, C.R. Genes that protect against the host-killing activity of the E3 protein of Bacillus subtilis bacteriophage SPO1. J. Bacteriol., 1995, 177, 2933-2937.
226. Losick, R.; Pero J. Cascades of Sigma factors. Cell, 1981, 25, 582-584.
227. Yuzenkova, Y.; Zenkin, N.; Severinov, K. Mapping of RNA polymerase residues that interact with bacteriophage Xp10 transcription antitermination factor p7. J. Mol. Biol., 2008, 375, 29-35.
228. Kaczanowska, M.; Ryden-Aulin, M. Ribosome biogenesis and the translation process in Escherichia coli. Microbiol. Mol. Biol. Rev., 2007, 71, 477-494.
229. Varea, J.; Monterroso, B.; Sáiz, J.L.; López-Zumel, C; García, J.L.; Laynez, J.; García, P.; Menéndez, M. Structural and thermodynamic characterization of Pal, a phage natural chimeric lysin active against pneumococci. J. Biol. Chem., 2004, 279, 43697-43707.
230. García, J.L.; García, E.; Arrarás, A.; García, P.; Ronda, C.; López, R. Cloning, purification, and biochemical characterization of the pneumococcal bacteriophage Cp-1 lysin. J. Virol., 1987, 61(8), 2573-2580.
231. Pérez-Dorado, I.; Campillo, N.E.; Monterroso, B.; Hesek, D.; Lee, M.; Páez, J.A.; García, P.; Martínez-Ripoll, M.; García, J.L.; Mobashery, S.; Menéndez, M.; Hermoso, J.A. Elucidation of the molecular recognition of bacterial cell wall by modular pneumococcal phage endolysin CPL-1. J. Biol. Chem., 2007, 282, 24990-24999.
232. Kikkawa, H.S.; Ueda, T.; Suzuki, S.; Yasuda, J. Characterization of the catalytic activity of the gamma-phage lysin, PlyG, specific for Bacillus anthracis. FEMS Microbiol. Lett., 2008, 286, 236-240.
233. Porter, C.J.; Schuch, R.; Pelzek, A.J.; Buckle, A.M.; McGowan, S.; Wilce, M.C.J.; Rossjohn, J.; Russell, R.; Nelson, D.; Fischetti, V.A.; Whisstock, J.C. The 1.6 A ° crystal structure of the catalytic domain of PlyB, a bacteriophage lysin active against Bacillus anthracis. J. Mol. Biol., 2007, 366, 540-550.
234. Son, B.; Yun, J.; Lim, J.A.; Shin, H.; Heu, S.; Ryu, S. Characterization of LysB4, an endolysin from the Bacillus cereus-infecting bacteriophage B4. BMC Microbiol., 2012, 15(12), 33.
235. Park, J.; Yun, J.; Lim, J.A.; Kang, D.H.; Ryu, S. Characterization of an endolysin, LysBPS13, from a Bacillus cereus bacteriophage. FEMS Microbiol. Lett., 2012, 332(1), 76-83.
236. Gaeng, S.; Scherer, S.; Neve, H.; Loessner, M.J. Gene cloning and expression and secretion of Listeria monocytogenes bacteriophagelytic enzymes in Lactococcus lactis. Apel. Environ. Microbiol., 2000, 66, 2951-2958.
237. Pritchard, D.G.; Dong, S.; Baker, J.R.; Engler, E.A. The bifunctional peptidoglycan lysin of Streptococcus agalactiae bacteriophage B30. Microbiol., 2004, 150, 2079-2087.
238. Baker, J.R.; Liu, C.; Dong, S.; Pritchard, D.G. Endopeptidase and glycosidase activities of the bacteriophage B30 lysin. Appl. Environ. Microbiol., 2006, 72, 6825-6828.
239. Takac, M.; Witte, A.; Blasi, U. Functional analysis of the lysis genes of Staphylococcus aureus phage P68 in Escherichia coli. Microbiol., 2005, 151, 2331-2342.
240. Loessner, M.J.; Gaeng, S.; Wendlinger, G.; Maier, S.K.; Scherer, S. The two-component lysis system of Staphylococcus aureus bacteriophage Twort: a large TTG-start holin and an associated amidase endolysin. FEMS Microbiol. Lett., 1998, 162(2), 265-274.
241. Navarre, W.W.; Ton-That, H.; Faull, K.F.; Schneewind, O. Multiple enzymatic activities of the murein hydrolase from staphylococcal phage phi11. Identification of a D-alanyl-glycine endopeptidase activity. J. Biol. Chem., 1999, 274(22), 15847-15856.
242. Donovan, D.M.; Lardeo, M.; Foster-Frey, J. Lysis of staphylococcal mastitis pathogens by bacteriophage phi11 endolysin. FEMS Microbiol. Lett., 2006, 265, 133-139.
243. Sass, P.; Bierbaum, G. Lytic activity of recombinant bacteriophage phi11 and phi12 endolysins on whole cells and biofilms of Staphylococcus aureus. Appl. Environ. Microbiol., 2007, 73, 347-352.
244. Obeso, J.M.; Martinez, B.; Rodriguez, A.; Garcia, P. Lytic activity of the recombinant staphylococcal bacteriophage phiH5 endolysin active against Staphylococcus aureus in milk. Int. J. Food. Microbiol., 2008, 128, 211-218.
245. Horgan, M.; O'Flynn, G.; Garry, J.; Cooney, J.; Coffey, A.; Fitzgerald, G.F.; Ross, R.P.; McAuliffe, O. The phage lysin, LysK, can be truncated to its CHAP domain and retain lytic activity against live antibiotic-resistant staphylococci. Appl. Environ. Microbiol., 2009, 75, 872-874.
246. Jun, S.Y.; Jung, G.M.; Son, J-S.; Yoon, S.Y.; Choi, Y.J.; Kang, S.Y. Comparison of the antibacterial properties of phage endolysins SAL-1 and LysK. Antimicrob. Agents Chemother., 2011, 55, 1764-1767.
247. Gupta R.; Prasad Y. P-27/HP Endolysin as antibacterial agent for antibiotic resistant Staphylococcus aureus of human infections. Curr. Microbiol., 2011, 63, 39-45.
248. Rodríguez-Rubio, L.; Martínez, B.; Rodríguez, A.; Donovan, D.M. García P. Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88 HydH5 virionassociated peptidoglycan hydrolase: fusions, deletions, and synergy with LysH5. Appl. Environ. Microbiol., 2012, 78(7), 2241-2248.
249. Abaev, I.; Foster-Frey, J.; Korobova, O.; Shishkova, N.; Kiseleva, N.; Kopylov, P.; Pryamchuk, S.; Schmelcher, M.; Becker, SC.; Donovan, D.M. Staphylococcal Phage 2638A endolysin is lytic for Staphylococcus aureus and harbors an inter-lytic-domain secondary translational start site. Appl. Microbiol. Biotechnol., 2012, epub ahead of print.
250. Wang, Y.; Sun, J.H.; Lu, C.P. Purified phage lysin LySMP: an extensive spectrum of lytic activity for swine streptococci. J. Curr. Microbol., 2009, 58, 609-615.
251. Yokoi, K.J.; Kawahigashi, N.; Uchida, M.; Sugahara, K.; Shinohara, M.; Kawasaki, K.I.; Nakamura, S.; Taketo, A.; Kodaira K.I. The two-component cell lysis genes holWMY and lysWMY of the 4 Staphylococcus warneri Mphage βWMY: Cloning, sequencing, expression, and mutational analysis in Escherichia coli. Gene, 2005, 351, 97-108.
252. Son, J.S.; Jun, S.Y.; Kim, E.B.; Park, J.E.; Paik, H.R.; Yoon, S.J.; Kang, S.H.; Choi Y.J. Complete genome sequence of a newly isolated lytic bacteriophage, EFAP-1 of Enterococcus faecalis, and antibacterial activity of its endolysin EFAL-1. J. Appl. Microbiol., 2010, 108, 1769-1779.
253. Uchiyama, J.; Takemura, I.; Hayashi, I.; Matsuzaki, S.; Satoh, M.; Ujihara, T.; Murakami, M.; Imajoh, M.; Sugai, M.; Daibata, M.; Characterization of lytic enzyme open reading frame 9 (ORF9) derived from Enterococcus faecalis bacteriophage jEF24C. Appl. Environ. Microbiol., 2011. 77, 580-585.
254. Proença, D.; Fernandes, S.; Leandro, C.; Silva, F.A.; Santos, S.; Lopes, F.; Mato, R.; Cavaco-Silva, P.; Pimentel, M.; São-José, C. Phage endolysins with broad antimicrobial activity against Enterococcus faecalis clinical strains. Microb. Drug Resist., 2012 18(3), 322-332.
255. Farkasovská, J.; Godány, A.; Vlcek, C. Identification and characterization of an endolysin encoded by the Streptomyces aureofaciens phage mu 1/6. Folia Microbiol., 2003, 48(6), 737-744.
256. Wittmann, J.; Eichenlaub, R.; Dreiseikelmann, B. The endolysins of bacteriophages CMP1 and CN77 are specific for the lysis of Clavibacter michiganensis strains, Microbiology, 2010, 156(8), 2366-2373.
257. Zimmer, M.; Vukov, N.; Scherer, S.; Loessner, M.J. The murien hydrolase of the bacteriophage phi3626 dual lysis system is active against all tested Clostridium perfringens strains. Appl. Environ. Microbiol., 2002, 68, 5311-5317.
258. Mayer, M.J.; Narbad, A.; Gasson M.J.; Molecular characterization of a Clostridium difficile bacteriophage and its cloned biologically active endolysin. J. Bacteriol., 2008, 190(2), 6734-6740.
259. Simmons, M.; Donovan, D.M.; Siragusa, G.R.; Seal, B.S. Recombinant expression of two bacteriophage proteins that lyse Clostridium perfringens and share identical sequences in the C-terminal cell wall binding domain of the molecules but are dissimilar in their N-terminal active domains. J. Agric. Food Chem., 2010, 58(19), 10330-10337.
260. Mayer, M.J.; Payne, J.; Gasson, M.J.; Narbad, A. Genomic sequence and characterization of the virulent bacteriophage phiCTP1 from Clostridium tyrobutyricum and heterologous expression of its endolysin. Appl. Environ. Microbiol., 2010, 76(16), 415-422.
261. http://jb.asm.org/content/190/20/6734.abstract Nariya, H.; Miyata, S.; Tamai, E.; Sekiya, H.; Maki, J.; Okabe, A. Identification and characterization of a putative endolysin encoded by episomal phage phiSM101 of Clostridium perfringens. Appl. Microbiol. Biotechnol., 2011, 90(6), 1973-1979.
262. Lai, M.J.; Lin, N.T.; Hu, A.; Soo, P.C.; Chen, L.K.; Chen, L.H.; Chang, K.C. Antibacterial activity of Acinetobacter baumannii phage AB2 endolysin (LysAB2) against both Gram-positive and Gram-negative bacteria, Appl. Microbiol. Biotechnol, 2011, 90(2), 529-539.
263. Sun, W.; Tan, Y.; Jia, M.; Hu, X.; Rao, X.; Hu, F. Functional characterization of the endolysin gene encoded by Pseudomonas aeruginosa bacteriophage PaP1. Afr. J. Microbiol. Res., 2010, 4, 933-939.
264. Van Hecke, K.; Briers, Y.; Derua, R.; Waelkens, E, Lavigne, R.; Van Meervelt, L. Structural analysis of bacteriophage-encoded peptidoglycan hydrolase domain KMV36C: crystallization and preliminary X-ray diffraction. Acta Crystallogr. Sect. F. Struct. Biol. Cryst. Commun., 2008, 1, 263-265.
265. Lim, J-A.; Shin, H.; Kang G-H.; Ryu, S. Characterization of endolysin from a Salmonella Typhimurium-infecting bacteriophage SPN1S. Res. Microbiol., 2012, 163(3), 233-241.
266. Mikoulinskaia, G.V.; Odinokova, I.V.; Zimin, A.A.; Lysanskaya, V.Y.; Feofanov, S.A.; Stepnaya, O.A. Identification and characterization of the metal ion-dependent L-alanoyl-D-glutamate peptidase encoded by bacteriophage T5. FEBS J., 2009, 276(24), 7329-7342.